Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Frédéric Courbon"'
Autor:
Delphine Vallot, Séverine Brillouet, Séléna Pondard, Lavinia Vija, Jean-Sébastien Texier, Lawrence Dierickx, Frédéric Courbon
Publikováno v:
EJNMMI Physics, Vol 11, Iss 1, Pp 1-13 (2024)
Abstract Background Peptide receptor radionuclide therapy with 177Lu-DOTATATE is a recognized option for treating neuroendocrine tumors and has few toxicities, except for the kidneys and bone marrow. The bone marrow dose is generally derived from a S
Externí odkaz:
https://doaj.org/article/f9bf2df61d2640009f45d2555143bb99
Autor:
Quentin Maronnier, Nesrine Robaine, Léonor Chaltiel, Lawrence O. Dierickx, Thibaut Cassou-Mounat, Marie Terroir, Lavinia Vija, Delphine Vallot, Séverine Brillouet, Chloé Lamesa, Thomas Filleron, Olivier Caselles, Frédéric Courbon
Publikováno v:
EJNMMI Physics, Vol 11, Iss 1, Pp 1-14 (2024)
Abstract Background Performance assessment of positron emission tomography (PET) scanners is crucial to guide clinical practice with efficiency. We have already introduced and experimentally evaluated a simulation method allowing the creation of a co
Externí odkaz:
https://doaj.org/article/7196d41f870a4e0a8f7f270bbc38876e
Publikováno v:
EJNMMI Physics, Vol 9, Iss 1, Pp 1-18 (2022)
Abstract Background Performance assessment of positron emission tomography (PET) scanners is crucial to guide clinical practice with efficiency. Even though clinical data are the final target, their use to characterize systems response is constrained
Externí odkaz:
https://doaj.org/article/e4eb276503ac4be4b47f345b306510be
Autor:
Marie Terroir, Chloé Lamesa, Mehdi Krim, Lavinia Vija, Jean-Sébastien Texier, Thibaut Cassou-Mounat, Jean-Pierre Delord, Delphine Vallot, Frédéric Courbon
Publikováno v:
Pharmaceuticals, Vol 16, Iss 5, p 754 (2023)
Salivary gland cancers are rare tumors comprising a large group of heterogeneous tumors with variable prognosis. Their therapeutic management at a metastatic stage is challenging due to the lack of therapeutic lines and the toxicity of treatments. [1
Externí odkaz:
https://doaj.org/article/712fe8040a3349178098e401949de3ac
Autor:
Franklin Gallo, Lavinia Vija, Sophie Le Grand, Nada Moukarbel, Koen Mortele, Erwan Gabiache, Frédéric Courbon, Suzanne Tavitian, Lawrence O. Dierickx
Publikováno v:
European Journal of Hybrid Imaging, Vol 3, Iss 1, Pp 1-4 (2019)
Abstract Mucormycosis is a life-threatening infection with most commonly rhino-orbital-cerebral and pulmonary syndromes that mostly occurs in immunocompromised patients. FDG-PET/CT emerged as a sensitive non-invasive tool to identify systemic mucormy
Externí odkaz:
https://doaj.org/article/163faaefdcc94c96803bfff17e8c9106
Autor:
Ben C. Allal, Frédéric Courbon, Pierre Canal, Séverine Brillouet, Thomas Filleron, Olivier Caselles, Philippe Rochaix, Fabienne Thomas, Jean-Pierre Delord, Sébastien Vergez
Supplementary Figure S1 and Supplementary Table S1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dba6a0b4083fdc3ccfd8c0e0f8a2df2
https://doi.org/10.1158/1078-0432.22441755.v1
https://doi.org/10.1158/1078-0432.22441755.v1
Autor:
Ben C. Allal, Frédéric Courbon, Pierre Canal, Séverine Brillouet, Thomas Filleron, Olivier Caselles, Philippe Rochaix, Fabienne Thomas, Jean-Pierre Delord, Sébastien Vergez
Purpose: There is a clinical need to identify predictive markers of the responses to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKI). Deoxy-2-[18F]fluoro-d-glucose positron emission tomography with computed tomography (18FDG-PE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5960a15a7b27053530620cf85c3e1a2d
https://doi.org/10.1158/1078-0432.c.6518691
https://doi.org/10.1158/1078-0432.c.6518691
Autor:
Dominique Clement, Shaunak Navalkissoor, Rajaventhan Srirajaskanthan, Frédéric Courbon, Lawrence Dierickx, Amy Eccles, Valerie Lewington, Mercedes Mitjavila, Juan Carlos Percovich, Benoît Lequoy, Beilei He, Ilya Folitar, John Ramage
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 49:3529-3537
Purpose NETTER-R aimed to determine the efficacy, safety and tolerability of 177Lu-DOTATATE in patients with progressive, advanced pancreatic neuroendocrine tumours (panNETs) using retrospective real-world data from multiple sites. Methods This inter
Publikováno v:
Current Radiopharmaceuticals. 15:164-172
Background: 177Lu-Dotatate is used in the treatment of somatostatin-receptor-positive inoperable progressive gastroenteropancreatic neuroendocrine tumors. A co-infusion of amino acids (AAs) is administered to prevent renal toxicity. Objective: This s
Autor:
Virginie Jacques, Lawrence Dierickx, Jean Sebastien Texier, Severine Brillouet, Frederic Courbon, Rosine Guimbaud, Lavinia Vija, Frederique Savagner
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
Background177Lu-oxodotreotide peptide receptor therapy (LuPRRT) is an efficient treatment for midgut neuroendocrine tumors (NETs) of variable radiological response. Several clinical, biological, and imaging parameters may be used to establish a relat
Externí odkaz:
https://doaj.org/article/c4f035a40e2341ee8b5185bf62dc846b